Albumin-based drug delivery: harnessing nature to cure disease
about
Global mapping of rat plasma proteins with a native proteomic approach using nondenaturing micro 2DE and quantitative LC-MS/MS.Evaluation of an Albumin-Binding Domain Protein Fused to Recombinant Human IL-2 and Its Effects on the Bioactivity and Serum Half-Life of the Cytokine.Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.Antiproliferative activity of (η(6)-arene)ruthenacarborane sandwich complexes against HCT116 and MCF7 cell lines.Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications.Role of Passive Diffusion, Transporters, and Membrane Trafficking-Mediated Processes in Cellular Drug Transport.Intrinsically Disordered Regions in Serum Albumin: What Are They For?Tannic acid-mediated surface functionalization of polymeric nanoparticlesAlbumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications.The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.Near-infrared remotely triggered drug-release strategies for cancer treatment.Engineering highly swellable dual-responsive protein-based injectable hydrogels: the effects of molecular structure and composition in vivo.Transcellular vesicular transport in epithelial and endothelial cells: Challenges and opportunities.Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.Spectroscopic investigation of the anticancer alkaloid piperlongumine binding to human serum albumin from the viewpoint of drug delivery.Lysine to arginine mutagenesis of chlorotoxin enhances its cellular uptake.Fabrication of Hemin-Doped Serum Albumin-Based Fibrous Scaffolds for Neural Tissue Engineering Applications.Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development.Distributions: The Importance of the Chemist's Molecular View for Biological Materials.Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia.Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy.Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects.Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
P2860
Q36161287-BFAB0F1D-541A-4BDA-80B0-22DD265E1EFBQ37611373-03A24D8C-7AE0-4066-AD48-AC9129A535A7Q38287887-37FF2C15-48C1-488C-BC70-66CE4B48E252Q38695135-AE019A74-B056-49A0-951A-2C6E6A8942CBQ38979811-F081015E-8BB5-4783-8D5C-BCA0D814D036Q38996441-02DD9938-DBCD-414D-8A2C-F872E42376EDQ39172489-C8188804-756B-4744-98EB-BF2C199F69FAQ41697936-0B9A63B9-04BD-4829-9D1E-2A540AB6324CQ46205951-AC3FF1CB-00FC-4D73-BEAC-31F58DD0DB2AQ47288556-0CF8C72A-05E5-4A66-86F0-6971C8FA0F90Q47318813-F527D271-77A4-4718-B08D-FBF2F977BB53Q47375942-3740BDD7-3459-4047-8B6B-A6379E7907E2Q47580688-62335AC0-1DA7-4B48-99D0-930BAB965597Q47595188-9EB77078-7BEC-4E93-AD6D-CAA837F701B8Q47729841-91CAA0A8-606B-4C2C-B3A6-9C897AD0F869Q47837467-3F586009-1D46-4688-81F6-A41FB756A26AQ48062572-153E9E10-BB13-41D8-A346-9685FB0B7270Q48142296-4D274563-F56A-4B44-9E9F-83AAE834F7A3Q52430441-BC121B4A-9176-4E0B-A607-497DC3FB2E99Q52583647-65A3EF0B-E71F-49C5-9981-173A9079C0F3Q52658028-4FE75EA7-C6CE-4075-9797-505AC0F851BBQ54237920-A07038CE-E903-4D92-9F10-1114D2BF562AQ55518839-8850C3CC-73E6-42B4-A48E-C42B2C05EF04Q58579072-43E95875-C8B3-4D8D-965C-DEB510776266
P2860
Albumin-based drug delivery: harnessing nature to cure disease
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Albumin-based drug delivery: harnessing nature to cure disease
@ast
Albumin-based drug delivery: harnessing nature to cure disease
@en
Albumin-based drug delivery: harnessing nature to cure disease
@nl
type
label
Albumin-based drug delivery: harnessing nature to cure disease
@ast
Albumin-based drug delivery: harnessing nature to cure disease
@en
Albumin-based drug delivery: harnessing nature to cure disease
@nl
prefLabel
Albumin-based drug delivery: harnessing nature to cure disease
@ast
Albumin-based drug delivery: harnessing nature to cure disease
@en
Albumin-based drug delivery: harnessing nature to cure disease
@nl
P2093
P2860
P1476
Albumin-based drug delivery: harnessing nature to cure disease
@en
P2093
Kenneth A Howard
Maja Thim Larsen
Matthias Kuhlmann
Michael Lykke Hvam
P2860
P2888
P356
10.1186/S40591-016-0048-8
P407
P577
2016-01-01T00:00:00Z
P6179
1046156327